KMT2A and acute lymphoblastic leukemia: Moreover, the 52 non-overlapping compounds more specifically affecting MLL-rearranged ALL cells, mostly were effective in only one of the three MLL-rearranged ALL cell lines, i.e., RS4;11 (Supplementary Figure S1A; top).